Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shaoma Zhijing granule
- Development stage
- Unknown
- Lead developer
- Tasly Pharmaceutical
- Administration
- Oral
01
Overview
Shaoma Zhijing granule is a Traditional Chinese Medicine (TCM) formulation developed by the Jiangsu Hospital of Traditional Chinese Medicine for the treatment of pediatric tic disorders, including Tourette syndrome. The granule is composed of several herbal ingredients, traditionally including *Paeonia lactiflora* (Baishao) and *Ephedra sinica* (Mahuang), and is designed to 'extinguish wind' and 'stop tremors' according to TCM principles. It is primarily used to alleviate motor and vocal tics in children. Clinical evaluation, including Phase IV trials, has focused on its safety and efficacy in reducing scores on the Yale Global Tic Severity Scale (YGTSS) compared to conventional pharmacological treatments like tiapride.
- Brand names
- Shaoma Zhijing granule
- Other names
- Shaoma Zhijing Keli芍麻止痉颗粒
02
Targets
DRD (Dopamine receptors)AR (Adrenergic receptors)GABA-B (Gamma-aminobutyric acid receptor type B)
Beyond the preview
Go deeper on Shaoma Zhijing granule.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Shaoma Zhijing granule.